27665 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 11
18:53 UTC
|
D.UN
Dream Office Real Estate Investment Trst
|
◎ Target | firm only | Hold | C$18.50→ C$19.00+2.7% |
|
Aug 11
18:53 UTC
|
D.UN
Dream Office Real Estate Investment Trst
|
◎ Target | firm only | Hold | C$18.50→ C$20.00+8.1% |
|
Aug 11
18:53 UTC
|
CTC.A
Canadian Tire
|
◎ Target | firm only | Buy | C$200.00→ C$217.00+8.5% |
|
Aug 11
18:53 UTC
|
CHRW
C.H. Robinson Worldwide
|
◎ Target | David Vernon ★★☆☆☆ #2357 | Market Perform | $153.00→ $151.00-1.3% |
|
Aug 11
18:53 UTC
|
CF
Canaccord Genuity Group
|
◎ Target | firm only | Buy | C$16.00→ C$18.00+12.5% |
|
Aug 11
18:53 UTC
|
CAR.UN
Canadian Apartment Properties REIT
|
◎ Target | firm only | Outperform | C$48.00→ C$43.00-10.4% |
|
Aug 11
18:53 UTC
|
B
Barrick Mining
|
◎ Target | firm only | Buy | $61.00→ $59.00-3.3% |
|
Aug 11
18:53 UTC
|
ASST
Strive
|
◎ Target | Mike Colonnese ★★★☆☆ #1150 | Buy | $37.00→ $36.00-2.7% |
|
Aug 11
18:53 UTC
|
ALS
Altius Minerals
|
◎ Target | firm only | C$60.00→ C$70.00+16.7% | |
|
Aug 11
18:53 UTC
|
ALMR
Alamar Biosciences
|
◎ Target | Daniel Arias ★★★★☆ #475 | Buy | $28.00→ $32.00+14.3% |
|
Aug 11
18:53 UTC
|
ABX
Barrick Gold
|
◎ Target | firm only | Outperform | C$58.00→ C$56.00-3.4% |
|
Aug 11
18:53 UTC
|
ABX
Barrick Gold
|
◎ Target | firm only | Sec→ r Perform | C$60.00→ C$57.00-5.0% |
|
Aug 11
18:53 UTC
|
ABX
Barrick Gold
|
◎ Target | firm only | Outperform | C$67.50→ C$70.00+3.7% |
|
Aug 11
18:53 UTC
|
ABBV
AbbVie
|
◎ Target | Navann Ty ★★☆☆☆ #2631 | Neutral | $218.00→ $247.00+13.3% |
|
Aug 11
18:53 UTC
|
MNDY
monday.com
|
↓ Downgrade | Alex Zukin ★★☆☆☆ #2509 | Outperform→ Peer Perform | |
|
Aug 11
18:53 UTC
|
BWMN
Bowman Consulting Group
|
↓ Downgrade | Aaron Spychalla ★★★★☆ #549 | Buy→ Hold | $43.00 |
|
Aug 11
18:53 UTC
|
ACVA
ACV Auctions
|
↓ Downgrade | firm only | Mkt Outperform→ Market Perform | |
|
Aug 11
18:53 UTC
|
SIA
Sienna Senior Living
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$25.00→ C$26.00+4.0% |
|
Aug 11
18:53 UTC
|
QMCO
Quantum
|
↑ Upgrade | Nehal Chokshi ★★★★☆ #856 | Market Perform→ Outperform | $24.00 |
|
Aug 11
18:53 UTC
|
CFW
Calfrac Well Services
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$7.50→ C$9.00+20.0% |
|
Aug 11
18:53 UTC
|
AC
Air Canada
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Sector Outperform | C$26.00→ C$33.50+28.8% |
|
Aug 11
17:53 UTC
|
VSEC
VSE
|
◎ Target | Scott Deuschle ★★★★☆ #455 | Buy | $280.00→ $290.00+3.6% |
|
Aug 11
17:53 UTC
|
RDNT
RadNet
|
◎ Target | David MacDonald not yet tracked | Buy | $90.00→ $94.00+4.4% |
|
Aug 11
17:53 UTC
|
NIQ
NIQ Global Intelligence
|
◎ Target | Faiza Alwy ★★★☆☆ #1513 | Hold | $14.00→ $15.00+7.1% |
|
Aug 11
17:53 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | George Hill ★★★★☆ #344 | Hold | $25.00→ $26.00+4.0% |
|
Aug 11
17:53 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Allen Lutz ★★☆☆☆ #2335 | Neutral | $30.00→ $32.00+6.7% |
|
Aug 11
17:53 UTC
|
DSP
Viant Technology
|
◎ Target | Tom White ★★★☆☆ #1556 | Buy | $16.50→ $17.50+6.1% |
|
Aug 11
17:53 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Geoff Meacham ★★☆☆☆ #2758 | Buy | $101.00→ $104.00+3.0% |
|
Aug 11
17:53 UTC
|
B
Barrick Mining
|
◎ Target | Lawson Winder ★★★☆☆ #1499 | Buy | $56.00→ $54.00-3.6% |
|
Aug 11
17:53 UTC
|
AIOT
PowerFleet
|
◎ Target | Anthony Stoss ★★★☆☆ #1746 | Buy | $9.00→ $6.00-33.3% |
|
Aug 11
17:53 UTC
|
ABCL
AbCellera Biologics
|
◎ Target | Robyn Kamaus not yet tracked | Buy | $12.00→ $30.00+150.0% |
|
Aug 11
17:53 UTC
|
ACVA
ACV Auctions
|
↑ Upgrade | firm only | Equal Weight→ Overweight | $10.50 |
|
Aug 11
16:53 UTC
|
UPWK
Upwork
|
◎ Target | Nat Schindler ★★☆☆☆ #2575 | Sec→ r Perform | $10.00→ $8.00-20.0% |
|
Aug 11
16:53 UTC
|
TRGP
Targa Resources
|
◎ Target | Elvira Scotto ★★★☆☆ #2196 | Outperform | $310.00→ $312.00+0.6% |
|
Aug 11
16:53 UTC
|
TASK
TaskUs
|
◎ Target | James Faucette ★★★☆☆ #2057 | Equal Weight | $6.00→ $7.00+16.7% |
|
Aug 11
16:53 UTC
|
STTK
Shattuck Labs
|
◎ Target | Joseph Pantginis ★★★☆☆ #2039 | Buy | $18.00→ $14.00-22.2% |
|
Aug 11
16:53 UTC
|
SLN
Silence Therapeutics
|
◎ Target | Michael Ulz ★★☆☆☆ #2835 | Overweight | $25.00→ $32.00+28.0% |
|
Aug 11
16:53 UTC
|
SKWD
Skyward Specialty Insurance Group
|
◎ Target | Andrew Kligerman ★★★★☆ #439 | Hold | $49.00→ $65.00+32.7% |
|
Aug 11
16:53 UTC
|
SGRY
Surgery Partners
|
◎ Target | Ben Hendrix ★★★☆☆ #1056 | Outperform | $20.00→ $19.00-5.0% |
|
Aug 11
16:53 UTC
|
SGRY
Surgery Partners
|
◎ Target | Ryan Langston ★★★☆☆ #1625 | Buy | $17.00→ $19.00+11.8% |
|
Aug 11
16:53 UTC
|
RPD
Rapid7
|
◎ Target | Matthew Hedberg ★★★☆☆ #1590 | Sec→ r Perform | $11.00→ $12.00+9.1% |
|
Aug 11
16:53 UTC
|
QTRX
Quanterix
|
◎ Target | Dan Brennan not yet tracked | Hold | $4.00→ $3.00-25.0% |
|
Aug 11
16:53 UTC
|
MDLN
Medline
|
◎ Target | Ivan Feinseth ★★★☆☆ #1607 | Buy | $62.00→ $55.00-11.3% |
|
Aug 11
16:53 UTC
|
LKFT
Lakefront Biotherapeutics American Depositary Shares
|
◎ Target | Judah Frommer ★★☆☆☆ #2309 | Equal Weight | $30.00→ $26.00-13.3% |
|
Aug 11
16:53 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Jeffrey Hung not yet tracked | Overweight | $280.00→ $283.00+1.1% |
|
Aug 11
16:53 UTC
|
INTU
Intuit
|
◎ Target | Jared Levine ★★☆☆☆ #2559 | Hold | $304.00→ $328.00+7.9% |
|
Aug 11
16:53 UTC
|
IMMX
Immix Biopharma
|
◎ Target | Judah Frommer ★★☆☆☆ #2309 | Overweight | $20.00→ $19.00-5.0% |
|
Aug 11
16:53 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Craig Hettenbach ★★★☆☆ #1942 | Equal Weight | $21.00→ $28.00+33.3% |
|
Aug 11
16:53 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Jonna Kim ★★★☆☆ #1345 | Hold | $25.00→ $30.00+20.0% |
|
Aug 11
16:53 UTC
|
GDRX
GoodRx
|
◎ Target | Charles Rhyee ★★★☆☆ #1560 | Buy | $4.00→ $5.00+25.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.